Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49055,297,1.26 [1.06-1.50],0.0080310217233344
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50824,391,1.14 [0.98-1.32],0.0936778537960805
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50298,2738,1.21 [1.14-1.28],4.918264941761579e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,50867,846,1.16 [1.05-1.29],0.0042332891325122
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49324,6949,1.15 [1.11-1.20],4.046400435815332e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49533,6354,1.21 [1.17-1.26],3.130984897887523e-23
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,50364,2407,1.12 [1.05-1.19],0.0004442809763168
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,50680,169,1.14 [0.90-1.44],0.2704895849944241
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46805,1932,1.21 [1.13-1.30],3.5174666622434493e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45207,2189,1.32 [1.24-1.41],5.592103628667677e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,44962,510,1.25 [1.10-1.43],0.0008174880449542
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35747,3930,1.22 [1.16-1.28],4.041312407814389e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44667,782,1.44 [1.30-1.60],1.8232671080507197e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,50792,2835,1.11 [1.05-1.17],0.0003548801760749
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,51022,1001,1.16 [1.06-1.28],0.0018816569102289
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49395,1835,1.26 [1.17-1.35],1.5716460350195447e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50889,2131,1.20 [1.12-1.28],6.624848248754654e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48350,393,1.14 [0.98-1.33],0.0875436728234196
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51121,98,1.35 [1.00-1.83],0.0525787698605229
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,50623,1865,1.19 [1.11-1.27],1.4348525348079153e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50664,153,1.15 [0.90-1.46],0.2568947500636647
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50960,313,1.25 [1.06-1.48],0.0089286418046269
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50923,276,1.28 [1.07-1.53],0.0072654845886658
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48386,826,1.30 [1.17-1.44],1.0010309318769596e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48111,551,1.13 [1.00-1.29],0.0509564356363769
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48176,219,1.17 [0.96-1.43],0.125348969764573
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51078,102,1.77 [1.32-2.36],0.0001258093598433
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50993,302,1.33 [1.12-1.57],0.0013600229005216
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,50790,99,1.18 [0.88-1.60],0.2713880367679165
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],50819,128,1.39 [1.07-1.81],0.0146760154247997
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,50539,577,1.02 [0.90-1.16],0.7079381818949981
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50945,114,1.07 [0.81-1.41],0.6388924817251471
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50911,123,0.87 [0.67-1.13],0.2889258872587164
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23478,129,1.21 [0.92-1.59],0.16666140609908
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",50463,2851,0.97 [0.92-1.03],0.3397932457036327
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,51094,114,1.06 [0.81-1.41],0.6583970655773994
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50993,128,1.01 [0.77-1.32],0.9407334004966452
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51072,213,1.01 [0.83-1.24],0.9214118632111976
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of ovary,27512,181,0.95 [0.77-1.19],0.6766394280352961
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51074,715,0.89 [0.79-0.99],0.0380461327607449
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,51076,585,0.90 [0.79-1.02],0.0905952378628215
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50907,147,0.90 [0.70-1.15],0.3900933738005013
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,51069,429,0.85 [0.74-0.98],0.0299769871243197
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,50990,696,0.93 [0.83-1.04],0.1975319011036269
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50891,1217,1.00 [0.92-1.09],0.9481680403536388
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51057,853,0.88 [0.79-0.97],0.0124202179864872
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Carcinoma in situ of breast,22368,139,1.03 [0.80-1.32],0.8272199623927009
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22459,168,0.99 [0.79-1.24],0.919789493824842
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40720,102,0.87 [0.64-1.17],0.3442401168760615
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40757,139,0.95 [0.74-1.23],0.706999870229758
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51022,237,1.05 [0.86-1.28],0.6196182724125796
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",51023,232,1.04 [0.86-1.27],0.6665663486367341
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,26606,585,0.96 [0.85-1.08],0.4850664428831915
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,35445,654,1.08 [0.96-1.22],0.1912791283179413
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,40720,102,0.89 [0.66-1.20],0.4522655543862643
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40985,367,1.11 [0.95-1.30],0.1887480757339319
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41018,400,1.13 [0.97-1.32],0.1159963520443019
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22595,190,1.01 [0.82-1.24],0.959892536795516
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40774,156,1.27 [1.00-1.62],0.0488471562872388
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40831,213,0.97 [0.79-1.20],0.7984938156807516
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",40815,197,1.19 [0.96-1.47],0.1151246247518622
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22547,142,0.83 [0.66-1.06],0.1396150787988813
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40801,183,1.00 [0.80-1.25],0.9879142034938162
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19596,1383,0.95 [0.88-1.03],0.2512399903296038
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",40845,227,0.91 [0.74-1.11],0.3400438624708776
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40766,148,0.94 [0.74-1.21],0.6531722447113606
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,40826,208,0.76 [0.62-0.93],0.0086236434503748
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,50736,396,1.16 [1.00-1.35],0.0514404959051524
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,51043,172,1.11 [0.88-1.40],0.3653470689245915
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanoma in situ,40682,158,0.97 [0.76-1.23],0.8027511815018991
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40800,182,0.94 [0.75-1.17],0.5569220263546941
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40937,319,1.05 [0.89-1.25],0.5457786872553113
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41061,443,1.02 [0.89-1.18],0.7508602471217489
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",40811,193,1.00 [0.81-1.25],0.969553601178015
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,50762,310,0.86 [0.73-1.02],0.0775807157827228
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42763,2145,0.93 [0.87-0.99],0.0338732780989552
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",42875,2257,0.94 [0.88-1.00],0.0450097586975251
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50544,680,1.09 [0.98-1.23],0.1217551458759586
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,47379,219,1.47 [1.20-1.80],0.0002011065515643
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50004,140,1.31 [1.02-1.68],0.0363127396599454
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49562,5742,1.20 [1.15-1.25],2.866921385574837e-19
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48209,99,1.21 [0.90-1.65],0.2104019227560197
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50297,100,1.08 [0.80-1.45],0.6235133995250939
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50170,3010,1.20 [1.14-1.27],5.7686063675538436e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50168,3008,1.20 [1.14-1.27],6.529615675157827e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47335,175,1.65 [1.31-2.07],1.654454560428083e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,50475,2365,1.29 [1.21-1.37],3.8843265159734847e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,50420,223,1.03 [0.84-1.25],0.7980154506993002
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,49990,126,1.20 [0.92-1.56],0.187008146299564
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,49982,118,1.06 [0.80-1.39],0.6899037421508651
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,50745,548,1.37 [1.20-1.55],1.6595094582648852e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,50916,110,1.33 [1.01-1.77],0.0434553128413262
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",50648,451,1.37 [1.19-1.58],1.4037706973388104e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48316,206,0.93 [0.76-1.15],0.5132969777029603
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39567,625,1.35 [1.20-1.52],9.834236448683824e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,47678,229,0.83 [0.69-1.01],0.060814205660919
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,47700,251,0.74 [0.61-0.90],0.0020348567911227
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39053,111,1.41 [1.06-1.88],0.0189819165775746
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,47482,136,1.35 [1.04-1.74],0.0228918493890377
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46362,463,0.96 [0.84-1.10],0.5598469514685731
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50184,1126,1.21 [1.11-1.32],3.6948617752144136e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,49583,525,1.07 [0.93-1.22],0.3533535340204554
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49312,254,1.04 [0.86-1.26],0.6982643332906953
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,50421,3075,1.09 [1.03-1.15],0.0025794121129469
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44541,2979,1.08 [1.02-1.14],0.0068674138878317
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39074,132,1.16 [0.89-1.51],0.2682432131941504
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47128,156,0.99 [0.78-1.25],0.9314673337952676
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39493,551,1.28 [1.12-1.45],0.0001827106315491
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39063,121,1.38 [1.05-1.82],0.0212459823722823
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45935,6993,0.98 [0.95-1.02],0.3179414756184811
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39318,376,1.23 [1.05-1.43],0.0100715930048025
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40037,1095,1.21 [1.10-1.32],4.3405758516918094e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50957,642,1.22 [1.08-1.37],0.0010813268886647
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50589,274,1.34 [1.12-1.60],0.0014390225005781
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39194,252,1.10 [0.91-1.33],0.332069757026441
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39064,122,1.41 [1.07-1.85],0.0132290656178336
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50053,3081,1.00 [0.95-1.06],0.943117507280918
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39450,508,1.44 [1.26-1.65],7.647554809795006e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39529,587,1.31 [1.16-1.49],1.8329897459011e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40191,1249,1.03 [0.94-1.12],0.5606527551596343
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39180,238,1.48 [1.22-1.80],8.319177226296218e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50572,257,1.33 [1.11-1.60],0.0022130821502558
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40131,1189,1.32 [1.21-1.44],8.59386185651765e-10
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,39896,954,1.11 [1.01-1.23],0.029636840200437
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46035,136,1.13 [0.87-1.46],0.3558565001659783
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,48793,9851,1.04 [1.00-1.07],0.0225519112897049
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47069,97,0.84 [0.63-1.14],0.262809192749216
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47082,110,1.12 [0.84-1.48],0.4477082110932264
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,50754,3842,0.95 [0.90-0.99],0.02253642945035
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",50756,3837,0.95 [0.90-0.99],0.0221165468926727
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47077,105,0.97 [0.73-1.29],0.8396669503569818
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,50439,2385,1.06 [1.00-1.13],0.0666624764412069
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42073,3131,1.25 [1.18-1.32],6.59185132883797e-16
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51095,445,1.80 [1.57-2.07],1.3950313195072404e-16
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49224,166,1.03 [0.81-1.31],0.7973058731516844
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48261,207,1.35 [1.10-1.67],0.0040838957177468
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48337,283,1.12 [0.94-1.34],0.1995685190338302
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39271,329,1.29 [1.10-1.52],0.002175526345755
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46514,301,2.02 [1.70-2.39],4.3738804953603565e-16
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4194,169,1.50 [1.19-1.89],0.0005349187553795
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4473,505,1.49 [1.31-1.70],1.5055743832306547e-09
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46337,124,1.83 [1.39-2.39],1.1512217911358087e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4134,112,2.06 [1.56-2.71],2.6743787074617215e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49859,3646,1.02 [0.97-1.07],0.4181883879478969
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,49758,700,1.13 [1.01-1.27],0.0329865229317977
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,46624,725,1.14 [1.03-1.28],0.0160785342135434
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40464,1522,1.22 [1.12-1.31],7.584063966104892e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50897,478,1.22 [1.06-1.39],0.0054265866168626
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),48904,325,1.28 [1.08-1.52],0.0042076448395706
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,46701,2365,1.06 [0.99-1.12],0.0819889728609642
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49054,475,1.21 [1.05-1.39],0.0091600135757431
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,48698,119,1.32 [1.00-1.74],0.0475302167991688
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48973,394,1.19 [1.03-1.39],0.0219401328675362
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31715,3749,1.13 [1.08-1.19],6.013483699347179e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,43095,863,1.25 [1.13-1.39],2.626789867130054e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51004,833,1.03 [0.93-1.14],0.586336398523615
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,28346,380,1.37 [1.17-1.60],7.400043481754424e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42571,339,1.28 [1.08-1.50],0.0034282980374316
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42422,190,1.20 [0.96-1.49],0.1029834763584451
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51118,98,1.00 [0.74-1.36],0.9911594780098448
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,44315,2083,1.22 [1.14-1.31],4.215294699555616e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,48406,4106,1.02 [0.97-1.06],0.5164915078339051
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44622,14948,1.01 [0.98-1.03],0.4727615312102812
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48384,517,1.25 [1.10-1.43],0.000952632182069
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,42376,144,1.21 [0.94-1.56],0.1333365270630554
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",50713,2170,1.24 [1.16-1.32],1.0087531035882411e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,46441,12849,0.99 [0.96-1.02],0.4100280286956166
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",46475,12883,0.99 [0.96-1.02],0.4985978812528294
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",50783,150,1.48 [1.15-1.89],0.0019729760440817
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33937,345,1.41 [1.20-1.66],3.801237609671724e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33859,267,2.16 [1.80-2.60],2.458359267349039e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,50836,2344,1.22 [1.14-1.29],7.005615992844101e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49295,215,1.08 [0.88-1.33],0.4570626293524457
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",48741,4405,1.01 [0.97-1.06],0.5540670479140122
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50373,1107,1.13 [1.03-1.24],0.0079463466048811
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,42949,717,1.16 [1.04-1.30],0.0105904979126888
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50160,1660,0.97 [0.90-1.04],0.3971010990488076
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45737,1401,1.00 [0.92-1.08],0.9682280043122476
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50934,309,0.97 [0.82-1.16],0.7536223065564177
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51061,617,1.10 [0.97-1.24],0.130845685617023
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,47973,106,1.38 [1.03-1.84],0.0333577757860154
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,48735,156,1.21 [0.95-1.54],0.1304852801385609
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43063,831,1.20 [1.08-1.33],0.0008439621066746
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48777,198,1.17 [0.95-1.45],0.1483859290204955
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49051,472,1.32 [1.15-1.52],7.293879084377194e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,42577,345,1.13 [0.96-1.33],0.1370076958036478
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,48059,192,1.29 [1.04-1.60],0.0210939294965412
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,47960,93,1.26 [0.93-1.72],0.1399557388168376
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48286,130,0.80 [0.61-1.04],0.0957667871581337
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48139,272,1.25 [1.04-1.49],0.0169589725989625
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44276,2044,1.22 [1.14-1.31],3.0008540079420862e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,48598,106,1.52 [1.13-2.03],0.0049894838463258
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49643,1064,1.27 [1.16-1.40],2.541107592124688e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49895,679,1.44 [1.28-1.61],5.377188016471928e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",49368,1212,1.15 [1.05-1.25],0.0016733448069332
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28639,673,1.30 [1.15-1.46],1.2333880358108524e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49315,797,1.23 [1.11-1.37],0.0001251806615471
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48544,677,1.24 [1.11-1.40],0.0002231332424087
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50159,943,1.21 [1.09-1.33],0.0001685610395526
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50979,1295,1.19 [1.09-1.29],5.171973038845616e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,42917,685,1.35 [1.20-1.52],4.647891120060985e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49884,668,1.45 [1.29-1.63],3.1119487985057573e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,48536,380,1.23 [1.05-1.43],0.0093725475209717
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50351,1271,1.11 [1.02-1.21],0.0125001895949913
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50310,1346,1.10 [1.01-1.20],0.0213297256748522
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49236,114,0.89 [0.67-1.18],0.4244480800443009
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,48736,158,1.04 [0.81-1.32],0.764733353257558
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49737,471,1.03 [0.89-1.18],0.7251324381050994
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49016,516,0.96 [0.84-1.10],0.5826346371212194
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,48703,836,1.24 [1.12-1.38],4.997010575267094e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,48607,171,1.34 [1.07-1.69],0.012035204853485
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50668,1482,1.21 [1.12-1.31],1.0820593532167528e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50879,708,0.81 [0.72-0.90],0.0001919093531425
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",44731,2817,1.07 [1.01-1.14],0.0134583769956961
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,49825,7911,1.04 [1.01-1.08],0.0181739577804663
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50786,838,0.83 [0.75-0.92],0.0003638464799163
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45045,3131,1.09 [1.03-1.15],0.0022146124057216
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42091,177,1.25 [1.00-1.57],0.0484611534820716
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,50068,2706,1.03 [0.97-1.09],0.3642680884978746
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45137,3223,1.00 [0.95-1.06],0.8672244301524178
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,50111,253,1.30 [1.07-1.57],0.0080303421716992
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,51120,649,1.11 [0.98-1.25],0.0974431666211642
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34486,117,1.17 [0.88-1.55],0.2901407905916659
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,47591,160,1.20 [0.95-1.52],0.1251503632118962
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48412,981,0.99 [0.90-1.09],0.8162135396828478
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,50313,454,1.01 [0.88-1.17],0.8644533028095678
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50961,644,1.12 [0.99-1.26],0.0629593386804549
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50132,100,1.00 [0.74-1.36],0.9968795396222812
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51086,121,0.95 [0.73-1.25],0.7363340351073994
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50004,145,1.11 [0.87-1.43],0.4061779078793879
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,48029,569,1.29 [1.13-1.46],9.247967076609673e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50177,2717,1.13 [1.06-1.19],4.285581718196433e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51038,1190,1.07 [0.98-1.17],0.136431288108777
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,49939,5112,1.11 [1.07-1.16],4.832415855942103e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,50365,107,1.72 [1.29-2.29],0.0002312656240726
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,50821,504,1.20 [1.05-1.37],0.0077050389330786
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,49980,121,0.81 [0.62-1.07],0.1343411793728789
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51083,138,1.13 [0.87-1.45],0.3576072422753646
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,47579,148,0.97 [0.76-1.24],0.834989045902012
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47588,157,1.13 [0.89-1.43],0.3321793569896273
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,49826,218,1.19 [0.97-1.46],0.1038000237049878
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,48168,708,1.09 [0.98-1.22],0.1247470881021417
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50982,639,1.09 [0.97-1.22],0.1664197738148417
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,34679,270,1.06 [0.88-1.28],0.5110350614838701
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50790,204,1.00 [0.81-1.24],0.9838166959803494
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49804,2373,1.04 [0.98-1.11],0.1928838721354003
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,48207,7469,1.08 [1.04-1.11],4.278063235133356e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,50428,396,1.24 [1.06-1.44],0.0059943565461497
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48240,809,1.04 [0.93-1.15],0.4891801990919653
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50972,590,1.24 [1.10-1.41],0.0005596801206617
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40668,1279,1.16 [1.07-1.27],0.0004459468665184
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50005,146,1.17 [0.91-1.50],0.2162199106258303
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50134,275,1.18 [0.99-1.41],0.0698831094208991
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50177,329,1.07 [0.90-1.26],0.4551082967667516
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,47621,190,1.22 [0.98-1.51],0.0725069834199023
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,47570,110,0.98 [0.75-1.30],0.9152464305331032
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,50882,1023,1.06 [0.97-1.17],0.2073818905463078
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,48565,1105,1.11 [1.02-1.22],0.0198393378683617
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,51073,838,1.04 [0.94-1.16],0.4319069063587506
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,49966,107,0.83 [0.63-1.10],0.1896776613836009
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,51119,157,1.05 [0.83-1.34],0.6693051382890229
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,50645,949,1.07 [0.97-1.18],0.1518643861990792
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,50480,98,1.38 [1.01-1.88],0.0400507854593756
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51093,326,1.08 [0.91-1.28],0.363020976932196
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,47533,102,0.88 [0.65-1.18],0.3779570811997773
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51120,656,1.10 [0.97-1.23],0.1327023832542752
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50040,246,1.30 [1.07-1.58],0.0078937973376388
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,49990,195,1.07 [0.86-1.33],0.5354767078183428
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50310,777,1.05 [0.94-1.17],0.3568470505429166
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50775,465,1.67 [1.46-1.91],1.5889165025152e-13
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49141,107,1.00 [0.75-1.33],0.9899669890263844
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49149,115,1.04 [0.78-1.37],0.8013872646254371
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",50908,102,1.12 [0.84-1.51],0.4388810815666517
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,50602,284,0.92 [0.77-1.10],0.3689237617645551
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4145,120,2.15 [1.65-2.80],1.2723378348806056e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5028,199,1.51 [1.23-1.86],0.0001071375264412
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,49981,186,0.88 [0.71-1.10],0.2541258343574566
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50698,2057,1.21 [1.14-1.30],9.107683197008734e-09
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50399,1365,0.99 [0.92-1.08],0.8999491617025969
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49473,439,0.96 [0.84-1.11],0.6083234516535475
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50950,1417,1.02 [0.94-1.10],0.6306755996623439
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51101,130,1.08 [0.83-1.40],0.5686289593518047
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,50800,1267,1.05 [0.96-1.14],0.2858913531798382
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51032,714,1.11 [0.99-1.24],0.0763231233842095
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,50935,354,1.02 [0.87-1.20],0.7696288218406001
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49149,115,1.05 [0.79-1.40],0.7239525476913291
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49166,132,0.96 [0.74-1.26],0.7854580628409656
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49145,111,0.80 [0.60-1.06],0.114847354463468
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50942,1384,1.08 [1.00-1.17],0.0519825183590219
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,49919,361,1.00 [0.86-1.17],0.974490339343076
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,49624,91,1.14 [0.83-1.56],0.4128806820125447
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,50512,194,1.18 [0.95-1.46],0.1316910439636285
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,50853,535,1.08 [0.94-1.22],0.2737029862828551
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,49913,380,1.05 [0.90-1.22],0.5481748838932473
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,50801,220,1.16 [0.95-1.42],0.1506053963751713
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50483,925,1.11 [1.01-1.23],0.0334207539335328
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50074,279,1.18 [0.98-1.40],0.0748119246519446
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,47955,4302,1.09 [1.05-1.15],0.0001150832650319
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,50780,462,1.06 [0.93-1.22],0.37825789264386
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51079,303,1.25 [1.06-1.49],0.0101026750956234
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49842,808,0.98 [0.88-1.09],0.7475129117067956
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,50443,125,1.20 [0.92-1.57],0.1851792591327566
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51076,105,1.15 [0.85-1.54],0.3626519052343088
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49201,167,1.07 [0.85-1.35],0.5562898012529903
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49326,292,0.96 [0.80-1.14],0.6079416944123377
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,48877,236,1.16 [0.96-1.42],0.1320731392345545
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,49657,124,0.86 [0.66-1.13],0.2796252308565943
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",48765,124,1.07 [0.82-1.41],0.6053435473102606
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,49726,168,1.20 [0.95-1.51],0.1252954941568501
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",49937,379,0.99 [0.85-1.15],0.8656607041589643
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49288,254,0.97 [0.81-1.17],0.7770653288137197
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,48861,220,1.17 [0.96-1.44],0.1207474280062251
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,48808,167,1.32 [1.05-1.67],0.0196303842355201
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47216,3563,1.12 [1.06-1.18],1.177011341719473e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49177,143,0.79 [0.61-1.01],0.0555270322052097
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50607,812,1.07 [0.97-1.19],0.1841418400509904
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,49913,118,1.18 [0.89-1.56],0.2437261806998087
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50135,340,1.23 [1.05-1.45],0.0109704025046528
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,50703,176,1.03 [0.83-1.29],0.7774044378813937
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51032,235,0.93 [0.76-1.13],0.4483830318790847
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,50859,256,1.18 [0.98-1.42],0.0887877616491518
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,50645,118,0.90 [0.68-1.18],0.4338879068254094
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,50650,123,1.08 [0.82-1.41],0.5901661635451451
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,50924,1781,1.09 [1.01-1.17],0.0237809132110636
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,50416,1273,1.13 [1.04-1.23],0.0042986363677336
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,49394,251,1.25 [1.04-1.51],0.0192562814656947
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49314,171,0.88 [0.70-1.11],0.2837636817677665
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,50640,149,0.97 [0.76-1.23],0.7941690444533506
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50914,423,1.07 [0.93-1.24],0.337684105470689
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,50617,126,1.13 [0.87-1.47],0.3637572568253652
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,47114,237,1.73 [1.43-2.10],2.77900914292994e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47109,232,1.72 [1.42-2.10],5.027768172308843e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35023,232,1.07 [0.88-1.31],0.4877029214164523
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,50857,552,0.94 [0.83-1.07],0.3604528249530331
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37755,3501,1.03 [0.98-1.08],0.2595361012428305
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38241,3450,1.03 [0.98-1.08],0.2697824723826643
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50310,272,1.24 [1.04-1.49],0.0191530218146515
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47037,160,1.39 [1.09-1.76],0.0073091622519181
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,44300,693,1.42 [1.27-1.59],1.965226704274705e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43718,111,1.00 [0.76-1.33],0.9745720870244262
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49120,5513,1.09 [1.05-1.14],2.6199281341059195e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",48404,141,1.04 [0.81-1.34],0.7511616955552451
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,48570,307,0.96 [0.81-1.13],0.6139051412727083
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",50723,2355,1.19 [1.12-1.27],5.753436800656677e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,48471,208,1.00 [0.81-1.23],0.9865172011833298
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47040,10421,1.09 [1.06-1.12],2.069416095704604e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48978,715,1.01 [0.91-1.13],0.8278707709568953
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,48988,620,1.21 [1.07-1.36],0.0024500288025328
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,44229,622,1.42 [1.26-1.61],1.6644983086321398e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48568,564,1.78 [1.57-2.02],2.8607044969595176e-19
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,50673,3796,1.20 [1.14-1.26],7.332775885297721e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,48636,632,1.72 [1.53-1.94],3.4862821102163387e-19
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,49146,1735,1.17 [1.09-1.26],3.239564816418435e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51094,652,1.25 [1.11-1.40],0.0002800587362338
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,48476,213,0.92 [0.75-1.13],0.4076568510213252
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50626,1914,1.33 [1.24-1.43],2.1655035992181271e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,50654,3941,1.15 [1.10-1.21],4.372865829969613e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49912,1649,1.00 [0.93-1.08],0.9900024351133784
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,46813,100,1.11 [0.82-1.51],0.4858628314062934
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50947,790,1.61 [1.45-1.80],1.1813751198603125e-18
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,50910,2577,1.14 [1.08-1.21],1.260850355793256e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,48669,1956,1.20 [1.12-1.28],2.934802393779064e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,47025,312,1.29 [1.09-1.54],0.0040191251546488
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50178,3301,1.20 [1.14-1.27],6.7397840167826025e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,50968,526,1.31 [1.15-1.50],5.531503028416854e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,46942,229,1.30 [1.06-1.59],0.0103513836317597
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,51071,470,0.95 [0.83-1.09],0.4394932335471391
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,50287,130,1.34 [1.03-1.74],0.0277733628940616
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,34898,107,1.41 [1.05-1.89],0.0214696368032818
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50582,1870,1.35 [1.26-1.45],1.2159618170655532e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,48817,554,0.94 [0.83-1.07],0.3605326279743353
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,47372,495,1.21 [1.06-1.39],0.0048655293512968
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",50343,409,1.12 [0.97-1.30],0.1213578806029123
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23586,220,1.15 [0.94-1.41],0.1717561542440636
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36096,127,1.04 [0.80-1.36],0.7752405729571602
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,50803,281,1.06 [0.89-1.27],0.5078145787412034
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,38484,178,1.07 [0.85-1.34],0.557510051744784
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,47470,363,1.02 [0.87-1.19],0.8190411374966926
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,50181,182,1.20 [0.96-1.50],0.1096532084800661
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,49354,143,0.98 [0.76-1.26],0.8857671222314529
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,39174,868,1.13 [1.02-1.25],0.0198303991659215
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47308,201,1.32 [1.07-1.63],0.0107589401960653
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50287,201,1.31 [1.06-1.62],0.0125477066746806
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,47510,403,1.12 [0.96-1.30],0.1524849510216414
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,49080,1973,1.04 [0.97-1.11],0.2313658341432669
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,38911,605,1.13 [1.00-1.28],0.0435716051884206
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47206,99,1.04 [0.77-1.40],0.8135682520376131
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",50836,203,1.63 [1.33-2.01],4.025896795376844e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,47931,249,2.09 [1.73-2.52],1.9966770605378864e-14
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,47784,161,1.26 [1.00-1.60],0.0519275672234249
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50815,368,0.93 [0.80-1.09],0.3889495212723267
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,50612,3315,1.10 [1.04-1.16],0.0003975743185033
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,47807,184,1.23 [0.98-1.53],0.0731362162503644
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50419,135,1.19 [0.92-1.54],0.1935219484719637
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47796,173,1.19 [0.95-1.50],0.1347141679950102
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,49650,452,1.03 [0.90-1.18],0.6738600227971911
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,45890,4396,1.08 [1.04-1.13],0.0005588414811808
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,50875,353,1.00 [0.85-1.18],0.972655654240348
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,50876,1665,1.07 [1.00-1.15],0.0676049078790288
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46835,8529,1.09 [1.05-1.12],6.251101581083742e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50293,1095,1.07 [0.98-1.18],0.1149353415133957
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50947,948,1.05 [0.95-1.16],0.3118675487893559
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49423,225,1.14 [0.93-1.39],0.2017693413944697
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49130,127,0.98 [0.75-1.27],0.8674193156455984
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,50501,2819,1.13 [1.07-1.20],1.30146220764027e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,49162,219,0.88 [0.72-1.08],0.2109609085958567
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49882,2775,1.05 [0.99-1.11],0.0907143315555734
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42213,6244,0.98 [0.95-1.02],0.3474181931935669
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,38701,395,1.13 [0.97-1.31],0.1236627195685413
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50955,318,1.01 [0.85-1.19],0.9405295990506484
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50945,112,0.98 [0.74-1.30],0.906805318122202
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,49457,246,1.62 [1.34-1.96],5.531046309654195e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36261,292,0.97 [0.81-1.15],0.6954662263917419
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39381,1075,1.05 [0.96-1.15],0.3193067457780388
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,39021,715,1.20 [1.07-1.35],0.0012938758597268
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43253,4947,1.06 [1.02-1.11],0.0065699342745707
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39375,1069,1.20 [1.09-1.32],0.000112707747277
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39598,16413,1.03 [1.01-1.06],0.0109419200545977
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,49990,2308,1.10 [1.03-1.17],0.0042612646239408
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49303,105,1.28 [0.96-1.70],0.0988025785256129
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,37908,2503,1.00 [0.94-1.06],0.9772679925922572
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49333,122,1.17 [0.89-1.53],0.2673253054253238
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,47909,6415,1.06 [1.02-1.10],0.0035190014747164
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,50959,104,0.98 [0.73-1.31],0.9021038149394376
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,36080,111,1.30 [0.97-1.73],0.0770568199103071
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,43281,1787,1.03 [0.95-1.10],0.491654198607822
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41698,204,1.06 [0.86-1.32],0.5834178637814944
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36161,192,1.33 [1.07-1.66],0.0094821158184551
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47970,288,2.04 [1.71-2.43],1.5071679882039021e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37057,1088,1.15 [1.05-1.26],0.0028601055132423
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51062,728,0.97 [0.87-1.08],0.547803481646745
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49119,1496,1.07 [0.99-1.16],0.0673350649870931
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49616,1993,1.08 [1.01-1.15],0.0295960582119709
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38676,370,1.04 [0.89-1.22],0.617342631148336
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,39485,1179,1.12 [1.03-1.22],0.0115466477883212
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51022,268,1.06 [0.89-1.28],0.5095950869766639
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,41629,135,0.91 [0.70-1.18],0.4671747307725934
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38661,2692,1.02 [0.97-1.09],0.4212310232165633
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47667,560,1.14 [1.00-1.29],0.0454562384992443
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,47419,312,0.94 [0.79-1.11],0.4427400351175818
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,39417,3448,1.01 [0.96-1.06],0.757980915472098
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,47152,11183,1.01 [0.99-1.04],0.3151100373966144
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49116,406,1.08 [0.93-1.25],0.319463163916745
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,50573,1362,1.06 [0.97-1.15],0.1818291920207493
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39621,1315,1.15 [1.05-1.25],0.0013669522230805
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,47408,301,1.16 [0.98-1.38],0.0882722960182532
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50815,816,1.03 [0.93-1.15],0.5218304276366953
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40188,1882,1.09 [1.02-1.17],0.0117803929686476
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50019,2337,1.10 [1.04-1.17],0.0022712540855156
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49568,370,1.10 [0.94-1.28],0.2482890639451416
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39378,3409,1.09 [1.03-1.14],0.0017177150430657
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42264,3958,1.15 [1.10-1.21],7.833735748671288e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,49406,195,1.51 [1.22-1.87],0.0001465891869992
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49373,1750,1.08 [1.01-1.16],0.030617633754926
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36651,682,1.09 [0.97-1.22],0.1578989174056436
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50925,129,1.05 [0.80-1.36],0.7363857151519023
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36938,969,1.14 [1.04-1.26],0.0073029808399602
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47977,295,0.97 [0.81-1.16],0.7412156375527151
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51098,111,0.92 [0.70-1.22],0.585998847593943
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49207,233,1.04 [0.86-1.27],0.6788248206328371
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,47733,110,0.89 [0.67-1.18],0.4266521737517751
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38831,525,1.11 [0.97-1.26],0.131671105854857
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,47939,316,1.10 [0.93-1.30],0.2849243205507668
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47884,261,1.19 [0.98-1.43],0.0723057095276344
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,42033,539,0.95 [0.83-1.08],0.39513853234537
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36317,348,1.13 [0.96-1.33],0.1385717414047239
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,42010,516,1.11 [0.97-1.26],0.1381076248617585
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,36124,155,1.20 [0.94-1.53],0.1477545641092332
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,50957,586,1.04 [0.92-1.18],0.525700798413585
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,50479,141,1.04 [0.81-1.33],0.7808306974847707
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47068,315,0.86 [0.73-1.01],0.0714651343338474
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49859,1380,1.14 [1.06-1.24],0.0010266470980357
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48825,346,1.09 [0.93-1.28],0.2715987483157447
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47565,812,1.37 [1.23-1.52],7.998179015982133e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,50507,546,1.06 [0.93-1.20],0.4052757176097361
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50917,956,1.12 [1.02-1.24],0.0199722462846598
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50058,97,1.22 [0.90-1.66],0.1938057465945394
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48039,6334,1.09 [1.05-1.13],6.8408385055868685e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50228,889,1.01 [0.92-1.12],0.8162686562056463
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49966,627,1.01 [0.90-1.14],0.8901667982751293
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50340,1861,1.14 [1.06-1.22],0.000213397372457
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51089,109,0.90 [0.68-1.20],0.4844351500227741
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,46865,112,1.77 [1.34-2.34],4.951929008344843e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49443,104,1.09 [0.81-1.46],0.5709302863681507
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,50486,525,1.07 [0.93-1.21],0.3424776098126831
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47653,900,1.15 [1.04-1.27],0.0082900651427716
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,46879,126,1.10 [0.84-1.44],0.5044045160358962
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,50944,164,1.17 [0.92-1.47],0.194321115491019
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48845,366,1.47 [1.26-1.72],1.1221110956497729e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50721,383,1.18 [1.01-1.38],0.0335981052237591
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50090,129,1.66 [1.28-2.16],0.0001538994643109
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,46883,130,1.31 [1.00-1.71],0.045944531784897
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,49977,3224,1.15 [1.09-1.21],3.465325678919791e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47728,975,1.14 [1.04-1.26],0.0074446590159038
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,46887,134,1.07 [0.82-1.39],0.6382164213108422
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50942,604,1.10 [0.97-1.24],0.1230361814815859
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50099,138,0.89 [0.69-1.14],0.3547419300187594
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50831,493,1.14 [1.00-1.30],0.0584846565208285
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51013,642,1.06 [0.94-1.19],0.3480988047759692
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46999,246,0.81 [0.67-0.97],0.0236721968827398
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47279,526,0.94 [0.82-1.07],0.331673772941695
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50992,621,1.04 [0.92-1.18],0.5037850187524306
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47222,469,1.56 [1.36-1.79],2.51902649154451e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51058,278,1.07 [0.90-1.29],0.4300550110627892
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,43858,219,0.98 [0.80-1.20],0.8417028667795718
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46527,11141,1.02 [0.99-1.05],0.2306733403973217
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43747,8361,1.03 [1.00-1.07],0.0551838942253611
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,43790,151,0.87 [0.68-1.10],0.2470093373542442
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44334,305,1.05 [0.88-1.24],0.5974337793987583
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44379,350,1.11 [0.95-1.31],0.1842123099799415
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,50634,177,0.92 [0.74-1.14],0.4359945060858877
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44227,198,1.14 [0.92-1.41],0.2492865753071872
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37625,2239,1.04 [0.98-1.11],0.2001704312656004
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50848,373,1.17 [1.00-1.36],0.0523250870141422
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44906,877,1.10 [1.00-1.22],0.0619103868105913
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43216,14353,1.02 [1.00-1.05],0.0930878445077104
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47194,226,1.20 [0.99-1.47],0.0689382157836509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,43938,299,1.12 [0.95-1.34],0.1849865743362738
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44760,1121,1.03 [0.95-1.13],0.4549747605725597
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49290,5261,1.05 [1.00-1.09],0.0313093353752002
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44180,541,0.96 [0.84-1.09],0.4918436186233261
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44069,430,1.06 [0.92-1.22],0.4115363305700749
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43904,265,1.05 [0.87-1.26],0.6290215500524385
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,49853,137,0.89 [0.69-1.14],0.3451522060302665
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38727,3341,0.96 [0.92-1.02],0.1751771165296885
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36575,1189,0.93 [0.85-1.01],0.1002517876704477
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50976,1173,0.93 [0.85-1.01],0.0866318432507634
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35534,148,0.94 [0.74-1.20],0.6221727211647283
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36044,658,1.01 [0.90-1.13],0.9008231934597644
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44241,602,0.93 [0.83-1.05],0.2556719278796881
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36648,1262,0.97 [0.89-1.06],0.5169314206844642
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44139,110,1.72 [1.29-2.29],0.0001938824333947
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45278,1249,1.05 [0.97-1.14],0.2509673766491929
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44626,597,1.01 [0.89-1.14],0.8843659727827036
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36564,1178,0.97 [0.89-1.06],0.4929142478244481
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,43799,160,1.13 [0.89-1.43],0.3155185714974836
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",43760,121,1.10 [0.84-1.44],0.5022657690603001
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47113,145,1.45 [1.13-1.86],0.0033480093519804
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,50350,3382,1.19 [1.13-1.25],4.9514462612750365e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49196,2228,1.23 [1.16-1.31],1.4359587659126906e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50835,886,1.07 [0.97-1.18],0.1907309364394543
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40313,4927,1.06 [1.02-1.11],0.0046385748402686
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35510,124,0.99 [0.76-1.29],0.93726090412773
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,43822,183,1.18 [0.95-1.48],0.1350014418114772
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35485,99,1.07 [0.79-1.46],0.6577053812431115
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35637,251,1.07 [0.89-1.29],0.4758423597456409
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47434,466,0.92 [0.80-1.05],0.2136570622083859
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,47718,750,1.25 [1.12-1.39],7.168160595565767e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51054,200,1.25 [1.01-1.55],0.0368340969166739
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47604,3575,1.05 [1.00-1.10],0.0526618415204163
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43839,200,1.04 [0.84-1.28],0.7060468996638352
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35656,270,1.09 [0.91-1.31],0.359766456763726
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45460,1431,1.01 [0.94-1.09],0.7639371123820679
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39638,4252,1.02 [0.98-1.07],0.3211389194386006
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,49901,185,1.03 [0.82-1.28],0.8209026834042852
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51081,135,1.08 [0.84-1.40],0.5455068835747083
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43801,162,1.03 [0.81-1.30],0.8096534276860242
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46103,2464,1.07 [1.01-1.14],0.0197039973215321
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,43817,178,1.05 [0.83-1.31],0.7016722399473692
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38577,3191,1.04 [0.99-1.10],0.1374902772160501
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47181,213,0.86 [0.70-1.05],0.1439134583780441
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,43747,108,1.13 [0.85-1.51],0.3989288413842012
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44339,310,1.04 [0.87-1.23],0.6872940210654879
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44729,1090,1.12 [1.02-1.22],0.0159864389795303
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50420,704,1.08 [0.97-1.21],0.1786742017358438
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45162,1133,1.17 [1.07-1.28],0.0005031478270942
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50859,860,1.08 [0.98-1.19],0.1370057123263786
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51075,107,1.36 [1.02-1.82],0.0365837224973444
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44012,373,0.96 [0.82-1.12],0.5979267057629483
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40477,1490,1.11 [1.02-1.19],0.0101000491671999
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44790,1151,1.12 [1.03-1.22],0.0113258302370829
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44093,454,0.90 [0.78-1.03],0.1328783401758794
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35491,105,1.03 [0.77-1.38],0.8606548707094389
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40278,4892,1.01 [0.97-1.06],0.556072761999383
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36680,1294,1.09 [1.00-1.18],0.0479275961863509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50180,464,0.99 [0.86-1.14],0.8795844408291369
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",50986,132,1.41 [1.09-1.83],0.0097626018393308
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",46841,100,1.03 [0.76-1.38],0.8619172227138564
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35524,138,1.08 [0.84-1.39],0.5585843893376492
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44226,197,1.05 [0.85-1.30],0.6347407150398912
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36284,898,1.07 [0.97-1.18],0.1874719396432193
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44248,609,0.98 [0.87-1.10],0.7274425325341549
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44527,498,1.15 [1.01-1.32],0.0342489166817937
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44398,369,1.17 [1.00-1.36],0.0521172406525188
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,39999,114,0.97 [0.74-1.29],0.853135191350561
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51083,115,1.36 [1.03-1.80],0.0308413818853603
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44811,1172,0.95 [0.87-1.04],0.252341049799717
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],49897,181,1.37 [1.10-1.70],0.005138961040426
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,48726,5087,1.03 [0.99-1.07],0.2052970048311316
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43899,260,1.09 [0.91-1.31],0.3582055576654657
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45098,1069,1.08 [0.98-1.18],0.1101787425773525
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48349,459,1.01 [0.88-1.16],0.8492599879582854
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,44438,409,1.04 [0.90-1.20],0.6150565525813536
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47098,3069,1.05 [0.99-1.10],0.1025765571449818
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46051,2022,1.05 [0.98-1.12],0.1372401119865032
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],43745,106,1.19 [0.89-1.59],0.2304507876146915
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49973,257,1.27 [1.06-1.52],0.0111580024757621
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43957,318,1.13 [0.96-1.34],0.1540469737180687
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,43789,150,1.20 [0.94-1.52],0.1446302729932223
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35500,114,1.17 [0.88-1.55],0.2869415243176981
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49058,3121,1.30 [1.24-1.38],6.39950393229539e-22
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20659,101,0.91 [0.68-1.21],0.519171213053627
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26895,111,1.03 [0.78-1.36],0.8407795079096042
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50488,637,1.01 [0.90-1.14],0.8330323358497567
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50017,166,0.85 [0.68-1.08],0.1888025714884772
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48953,3016,1.50 [1.42-1.58],1.9555634800485583e-47
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,50691,160,1.93 [1.53-2.44],3.198442934079982e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,50639,594,1.06 [0.93-1.20],0.3713466759785113
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,45012,460,1.11 [0.97-1.28],0.1396639009911327
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,46093,156,2.22 [1.75-2.82],4.9208923310392096e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22265,3293,1.06 [1.01-1.12],0.0267045344296111
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27128,344,0.91 [0.78-1.06],0.2302926366070933
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20738,180,0.97 [0.78-1.21],0.8054841886180258
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20958,400,0.87 [0.75-1.00],0.0510968183594642
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21574,1016,0.94 [0.86-1.03],0.2184931205954311
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42676,10630,1.09 [1.06-1.13],1.3704526212302902e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,50697,166,2.21 [1.76-2.77],9.217766724478048e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19176,204,1.22 [0.98-1.51],0.0701252321631616
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,45921,586,1.10 [0.97-1.25],0.1425960071839643
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21554,2582,1.09 [1.02-1.15],0.0078896811092972
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27043,404,0.89 [0.77-1.03],0.1223082036001802
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19205,233,1.02 [0.84-1.25],0.8104150297799564
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27127,130,0.76 [0.59-0.97],0.0265583058753252
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20866,308,0.89 [0.76-1.05],0.1712543133520006
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44706,154,1.46 [1.15-1.86],0.0021372961256104
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23026,2468,0.99 [0.93-1.05],0.636705681185184
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19078,106,0.91 [0.68-1.22],0.5192398262149247
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20697,139,1.16 [0.90-1.49],0.241623480158619
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51093,127,0.91 [0.70-1.19],0.4889161620926328
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51104,133,0.99 [0.76-1.28],0.9194664581987144
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49037,4485,1.11 [1.06-1.16],1.2487641156505743e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45973,1421,1.08 [1.00-1.18],0.0489549763314036
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26904,120,0.70 [0.55-0.91],0.0064508649940241
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50988,943,1.11 [1.01-1.23],0.035463290254561
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19279,307,1.17 [0.98-1.39],0.0752820601569502
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19252,280,1.03 [0.85-1.23],0.788902856920794
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19204,232,1.07 [0.88-1.32],0.4852033852272797
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51040,139,0.91 [0.71-1.17],0.4701181450373778
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48013,3461,1.15 [1.09-1.21],9.080998410930004e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26847,208,0.86 [0.71-1.05],0.1408247530446807
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20712,154,0.94 [0.74-1.19],0.6202085142475084
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20930,372,0.93 [0.80-1.08],0.3131151876382221
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20671,113,1.04 [0.78-1.37],0.7995514726276475
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20762,204,0.96 [0.78-1.17],0.6748022943863043
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46017,682,1.12 [1.00-1.26],0.0525922930039633
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,50358,313,1.14 [0.96-1.35],0.1349930796963949
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20872,314,1.06 [0.90-1.25],0.4879021604256326
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20666,108,0.98 [0.74-1.30],0.8776354879000237
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21208,650,0.95 [0.85-1.06],0.3739319591210153
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20718,160,1.12 [0.88-1.41],0.3563411644780427
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21142,584,1.06 [0.94-1.20],0.3073538746713461
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,50628,97,1.35 [0.99-1.83],0.054521794971974
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19237,265,1.00 [0.83-1.21],0.9788047844108332
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,50625,5290,1.28 [1.23-1.34],5.87245015110757e-32
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",45575,240,1.28 [1.06-1.55],0.0120020494771532
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46192,255,1.39 [1.15-1.68],0.000701844536227
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49961,110,1.13 [0.85-1.50],0.4038354202528138
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44992,440,1.06 [0.91-1.22],0.4562852568219553
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50637,786,0.99 [0.89-1.10],0.8315469030050755
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20698,140,0.93 [0.73-1.19],0.5864609512214786
